Amgen files quarterly report (10-Q) for the period ended Sep 30, 2025

Amgen filed its quarterly report on Form 10-Q with the SEC on Nov 4, 2025, 6:59 PM ET, covering the quarter ended Sep 30, 2025. It reports fiscal Q3 2025 results.

• Revenue: $9.56B (+12.4% from $8.50B a year earlier)
• Operating income: $2.53B (+23.4% from $2.05B a year earlier)
• Net income: $3.22B (+13.6% from $2.83B a year earlier)
• Diluted EPS: $5.93 (+13.6% from $5.22 a year earlier)
• Form 10-Q accepted by EDGAR Nov 4, 2025, 6:59 PM ET
• Accession number 0000318154-25-000072

SEC filing 10-Q · accession 0000318154-25-000072 · sec.gov ↗